Cook L S, Straub K D, Doherty J E, Whittle J L, Baker B J
J Cardiovasc Pharmacol. 1983 May-Jun;5(3):446-9.
It has been documented that biogenic amines can stimulate Na+, K+-ATPase from various tissue preparations. However, it is unclear whether or not this stimulation occurs in myocardial tissues. We have evaluated possible catecholamine stimulation of purified Na+, K+- ATPase preparations utilizing a bovine ventricular microsomal preparation. We have studied the dose response of the enzyme to ouabain and digitoxigenin in the presence and absence of propranolol and norepinephrine. Our results indicate that propranolol increases the sensitivity of Na+, K+-ATPase to inhibition by digitalis, and that stimulation of Na+, K+-ATPase in bovine myocardium is not mediated via an adrenergic mechanism. In addition, our results indicate that in myocardial tissue, both stereoisomers of propranolol produce a direct nonspecific membrane effect which can modify Na+, K+-ATPase activity.
据记载,生物胺可刺激来自各种组织制剂的钠钾ATP酶。然而,这种刺激是否发生在心肌组织中尚不清楚。我们利用牛心室微粒体制剂评估了纯化的钠钾ATP酶制剂可能受到的儿茶酚胺刺激。我们研究了在有和没有普萘洛尔及去甲肾上腺素的情况下,该酶对哇巴因和洋地黄毒苷的剂量反应。我们的结果表明,普萘洛尔增加了钠钾ATP酶对洋地黄抑制的敏感性,并且牛心肌中钠钾ATP酶的刺激不是通过肾上腺素能机制介导的。此外,我们的结果表明,在心肌组织中,普萘洛尔的两种立体异构体都会产生直接的非特异性膜效应,这种效应可改变钠钾ATP酶的活性。